Abstract
Topoisomerase II (TOP2) relieves torsional stress by forming transient cleavage complex intermediates (TOP2ccs) that contain TOP2-linked DNA breaks (DSBs). While TOP2ccs are normally reversible, they can be “trapped” by chemotherapeutic drugs such as etoposide and subsequently converted into irreversible TOP2-linked DSBs. Here, we have quantified etoposide-induced trapping of TOP2ccs, their conversion into irreversible TOP2-linked DSBs, and their processing during DNA repair genome-wide, as a function of time. We find that while TOP2 chromatin localization and trapping is independent of transcription, it requires pre-existing binding of cohesin to DNA. In contrast, the conversion of trapped TOP2ccs to irreversible DSBs during DNA repair is accelerated 2-fold at transcribed loci relative to non-transcribed loci. This conversion is dependent on proteasomal degradation and TDP2 phosphodiesterase activity. Quantitative modeling shows that only two features of pre-existing chromatin structure—namely, cohesin binding and transcriptional activity—can be used to predict the kinetics of TOP2-induced DSBs.
| Original language | English |
|---|---|
| Pages (from-to) | 252-266.e8 |
| Journal | Molecular Cell |
| Volume | 75 |
| Issue number | 2 |
| DOIs | |
| State | Published - 25 Jul 2019 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019
Funding
We thank Sam John for comments on the manuscript; Barry Sleckman for the pre-B cell lines and Masato Kanemaki for HCT116 RAD21-mAID cells; Fred Alt for discussions; Yoram Louzoun for advice on quantitative modeling; Jennifer Wise and Kelly Smith for assistance with animal work; Xuguang Tai for assistance on primary lymphocytes isolation; and David Goldstein and the CCR Genomics core for sequencing support. Y.P. and S.N.H. are supported by the Intramural Program of the NIH , Center for Cancer Research ( Z01 BC006161 ). Research in the laboratory of J.-M.P. is funded by Boehringer Ingelheim and grants by the Austrian Research Promotion Agency ( FFG - 834223FFG - 852936 ) and the European Research Council H2020 ( 693949 ). A.C. is in part supported by the Kyoto University Hakubi Project. The A.N. laboratory is supported by the Intramural Research Program of the NIH , an Ellison Medical Foundation Senior Scholar in Aging Award ( AG-SS-2633-11 ), the Department of Defense Idea Expansion ( W81XWH-15-2-006 ) and Breakthrough ( W81XWH-16-1-599 ) Awards, the Alex Lemonade Stand Foundation Award, and an NIH Intramural FLEX Award.
| Funders | Funder number |
|---|---|
| Center for Cancer Research | Z01 BC006161 |
| Department of Defense Idea Expansion | W81XWH-15-2-006, W81XWH-16-1-599 |
| National Institutes of Health | |
| National Cancer Institute | ZIABC010959 |
| Ellison Medical Foundation | AG-SS-2633-11 |
| Boehringer Ingelheim | |
| Alex's Lemonade Stand Foundation for Childhood Cancer | |
| H2020 European Research Council | 693949 |
| Österreichische Forschungsförderungsgesellschaft | 834223FFG - 852936 |
| Kyoto University |
Keywords
- 3D chromatin organization
- DNA double-strand breaks
- TDP2
- chromosomal translocations
- cohesin
- proteasome
- quantitative modeling
- topoisomerase
- topoisomerase 2 cleavage complex
- transcription
Fingerprint
Dive into the research topics of 'Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver